| Filed On | Filing |
|---|---|
| 18 Jun 2019 |
8-K/A: Termination of a Material Definitive Agreement; Regulation FD Disclosure +1 more
BeiGene Announces Clinical Results from Three Posters on Zanubrutinib Presented at the 24th Congress of European Hematology Association (EHA) |
Loading...